Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 3 1Phase 2 1

Status

Recruiting 5Completed 3No longer available 1Available 1

Sponsor Class

OTHER 3NIH 2

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Endocrine 5CNS 4NET 1

Conditions

Insulinoma 2Hypoglycemia 2Hyperinsulinism 2Congenital Hyperinsulinism 2Pheochromocytoma 1Parkinson Disease 1Neuroendocrine Tumors 1Neuroblastoma 1Lewy Body Disease 1Infant, Newborn, Diseases 1Glucose Metabolism Disorders 1Endocrine System Diseases 1Carcinoid Tumor 1Brain Neoplasms 1

Interventions

lutetium Lu 177 dotatate 16Magnetic Resonance Spectroscopy 14gallium Ga 68 dotatate 9Specimen Handling 8Everolimus 8pembrolizumab 7cabozantinib 6Cisplatin 6fluorodopa F 18 5Etoposide 5trametinib 4surufatinib 4lanreotide 4dabrafenib 4cemiplimab 4X-Rays 4Temozolomide 4Nivolumab 4Lutetium-177 4Lutetium 4Fluorodeoxyglucose F18 4Carboplatin 4177Lu-octreotide, DOTA(0)-Tyr(3)- 4olaparib 3lenvatinib 3copper dotatate CU-64 3Transurethral Resection of Prostate 3Thyrotropin Alfa 3Surveys and Questionnaires 3Somatostatin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Recruiting × fluorodopa F 18 × Endocrine × Clear all
NCT00646022 2026-05-12

Natural History of Familial Carcinoid Tumor

National Institutes of Health Clinical Center (CC)

Recruiting
1,600 enrolled
Endocrine

Carcinoid Tumor

NCT00004847 2026-05-07

Diagnosis of Pheochromocytoma

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
3,000 enrolled
Endocrine

Endocrine System Diseases, Pheochromocytoma

NCT04706910 2026-02-09

18F-DOPA II - PET Imaging Optimization

University of Alberta

Phase 3 Recruiting
800 enrolled
CNSEndocrineNET

Brain Neoplasms, Neuroblastoma, Parkinson Disease, Neuroendocrine Tumors, Lewy Body Disease, Congenital Hyperinsulinism

NCT05088798 2025-12-19

18FDOPA HI

Washington University School of Medicine

Phase 2 Recruiting
100 enrolled
Endocrine

Hyperinsulinism, Hypoglycemia, Infant, Newborn, Diseases, Insulinoma, Glucose Metabolism Disorders

NCT02021604 2024-07-16

Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma

Cook Children's Health Care System

Phase 1 Recruiting
250 enrolled
Endocrine

Hyperinsulinism, Hypoglycemia, Insulinoma, Congenital Hyperinsulinism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡